These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31923008)

  • 21. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
    Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A; Guha M; Noutsias M; Klein HH; Klein HU
    Herz; 2019 Aug; 44(5):379-389. PubMed ID: 29234842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerometery as a measure of modifiable physical activity in high-risk elderly preoperative patients: a prospective observational pilot study.
    Grimes L; Outtrim JG; Griffin SJ; Ercole A
    BMJ Open; 2019 Nov; 9(11):e032346. PubMed ID: 31685513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wearable Cardioverter Defibrillator-Guided 6-Min Walk Test Performed at Home Is Accurate and Reliable: RESULTS OF THE TRENDS STUDY.
    Burch AE; Scherr D; Rieth A; Griffin J; Bianco NR; Odeneg T; Sears SF
    J Cardiopulm Rehabil Prev; 2020 Mar; 40(2):E14-E17. PubMed ID: 31343585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S; Ilyas S; Siddiqui F; Ando T; Shokr M; Panaich S; Briasoulis A; Afonso L; Khan M
    Acta Cardiol; 2020 Dec; 75(8):695-704. PubMed ID: 31687917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators.
    Mehta NA; Abdulsalam N; Kouides R; Ahmed H; Atif R; Shah A; Taylor S; Chuprun D; Huang D; Rao M
    Clin Cardiol; 2020 Mar; 43(3):260-266. PubMed ID: 31860745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey.
    Lenarczyk R; Potpara TS; Haugaa KH; Hernández-Madrid A; Sciaraffia E; Dagres N;
    Europace; 2016 Jan; 18(1):146-50. PubMed ID: 26842735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of body mass index on the wearable cardioverter defibrillator shock efficacy and patient wear time.
    Wan C; Szymkiewicz SJ; Klein HU
    Am Heart J; 2017 Apr; 186():111-117. PubMed ID: 28454824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis.
    Salehi N; Nasiri M; Bianco NR; Opreanu M; Singh V; Satija V; Jhand AS; Karapetyan L; Safadi AR; Surapaneni P; Thakur RK
    Can J Cardiol; 2016 Oct; 32(10):1247.e1-1247.e6. PubMed ID: 26975224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wearable cardioverter-defibrillators in pediatric cardiomyopathy: A cost-utility analysis.
    Evers PD; Anderson JB; Ryan TD; Czosek RJ; Knilans TK; Spar DS
    Heart Rhythm; 2020 Feb; 17(2):287-293. PubMed ID: 31476408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?
    Kachur S; Morin DP
    Curr Cardiol Rep; 2019 Sep; 21(10):125. PubMed ID: 31494744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with wearable cardioverter defibrillators at a tertiary electrophysiology program.
    Bossory L; Schubert S; Afzal MR; Weiss R; Tyler J; Kalbfleisch S; Augostini R; Hummel J; Okabe T; Daoud EG; Houmsse M
    Pacing Clin Electrophysiol; 2018 Nov; 41(11):1491-1494. PubMed ID: 30191582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study.
    Garcia R; Warming PE; Narayanan K; Defaye P; Guedon-Moreau L; Blangy H; Piot O; Leclercq C; Marijon E;
    Europace; 2023 May; 25(5):. PubMed ID: 37021342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C
    Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
    Barsheshet A; Vamvouris T; Goldenberg I
    Expert Rev Med Devices; 2016 Jul; 13(7):627-32. PubMed ID: 27333818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    Clin Cardiol; 2017 Aug; 40(8):586-590. PubMed ID: 28333373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and Implications of Ischemia Prior to Ventricular Tachyarrhythmia in Patients Treated With a Wearable Cardioverter Defibrillator Following Myocardial Infarction.
    Kandzari DE; Perumal R; Bhatt DL
    Clin Cardiol; 2016 Jul; 39(7):399-405. PubMed ID: 27341494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.